This prespecified secondary analysis of a randomized clinical trial investigates the association of apalutamide alone or apalutamide plus abiraterone acetate and prednisone with health-related quality of life in patients with advanced castration-sensitive prostate cancer.
Wafik El-Deiry: Outstanding news of acceptance of a manuscript with translational relevance in oncology / cancer, OncoDaily, Oncology, Wafik El-Deiry
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
Nature – The idea that evolution is driven by an organism’s development — not just the natural selection of its genes — challenges a dearly…
Sorry, I don’ t understand. Please try again The first interim analysis of the Phase 2 COCOON study met its primary endpoint, demonstrating that an…
Dr Bishal Gyawali discusses tips for reading a phase 3 clinical trial publication, focusing on the introduction and methods sections.
He’s called Dr. Ed — that’s Edward T. Creagan, MD, a cancer specialist, the first Mayo Clinic doctor board certified in hospice and palliative medicine.…
In just 50 years, Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for its expertise…
This case-control study assesses imaging and autopsy data from patients with dementia with Lewy bodies and probable dementia with Lewy bodies to investigate longitudinal change…
Charlotte Osborn-Forde from the National Academy for Social Prescribing explains the findings from a new report that assessed the impact of social prescribing on health…
This informative article covers all aspects of leukemia, from its various types and clinical presentations to diagnostic investigations and treatment options. Whether you’re a healthcare…
